Corporate News     14-Jan-16
Astrazeneca Pharma India to hold board meeting
On 6 February 2016
Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 6 February 2016, to consider and approve the Unaudited Financial Results of the Company for the quarter ended 31 December 2015.
Previous News
  Astrazeneca Pharma India standalone net profit declines 46.08% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   07:42 )
  Board of Astrazeneca Pharma India recommends interim dividend
 ( Corporate News - 09-Aug-21   20:10 )
  Astrazeneca Pharma India standalone net profit declines 2.44% in the March 2020 quarter
 ( Results - Announcements 18-May-20   18:30 )
  Astrazeneca Pharma India schedules board meeting
 ( Corporate News - 25-May-23   15:01 )
  AstraZeneca Pharma India terminates distribution services agreement with Sun Pharma
 ( Corporate News - 28-May-21   12:47 )
  Astrazeneca Pharma gains after CDSCO nod to sale Tremelimumab solution
 ( Hot Pursuit - 02-Jun-23   10:05 )
  AstraZeneca Pharma India terminates its distribution agreement with Abbott Healthcare
 ( Corporate News - 28-May-21   12:00 )
  Astrazeneca Pharma India standalone net profit rises 57.94% in the September 2019 quarter
 ( Results - Announcements 11-Nov-19   16:51 )
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 10-Aug-21   10:00 )
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 08-Aug-19   10:11 )
  Astrazeneca Pharma India reports standalone net loss of Rs 2.88 crore in the March 2017 quarter
 ( Results - Announcements 10-May-17   13:41 )
Other Stories
  Adani Ports records 14% growth in cargo volumes in September 2024
  03-Oct-24   09:37
  SignatureGlobal India launches new project in Gurugram
  03-Oct-24   09:34
  Biocon Biologics refinances debt through USD bonds and syndicated term loan
  03-Oct-24   09:29
  RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
  03-Oct-24   09:26
  Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
  03-Oct-24   09:23
  Transformers & Rectifiers India wins order of Rs 565 cr
  03-Oct-24   09:07
  Tata Motors records 12% decline in Q2 sales
  01-Oct-24   18:04
  Tata Motors records 15% decline in September sales
  01-Oct-24   17:55
  Man Infra set to launch its highly anticipated Vile Parle project
  01-Oct-24   17:48
  Padam Cotton Yarns to declare Quarterly Result
  01-Oct-24   17:39
Back Top